Publication: Vaccination against the Epstein–Barr virus
Vaccination against the Epstein–Barr virus
Date
Date
Date
Citations
Rühl, J., Leung, C. S., & Münz, C. (2020). Vaccination against the Epstein–Barr virus. Cellular and Molecular Life Sciences, 77(21), 4315–4324. https://doi.org/10.1007/s00018-020-03538-3
Abstract
Abstract
Abstract
Epstein–Barr virus (EBV) was the first human tumor virus being discovered and remains to date the only human pathogen that can transform cells in vitro. 55 years of EBV research have now brought us to the brink of an EBV vaccine. For this purpose, recombinant viral vectors and their heterologous prime-boost vaccinations, EBV-derived virus-like particles and viral envelope glycoprotein formulations are explored and are discussed in this review. Even so, cell-mediated immune control by cytotoxic lymphocytes protects healthy virus carrie
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
- Rühl, Julia
- Leung, Carol S
- Münz, Christian
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Keywords
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Downloads
Views
Citations
Rühl, J., Leung, C. S., & Münz, C. (2020). Vaccination against the Epstein–Barr virus. Cellular and Molecular Life Sciences, 77(21), 4315–4324. https://doi.org/10.1007/s00018-020-03538-3
